KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Debt Ratio: 2018-2025

Historic Debt Ratio for Esperion Therapeutics (ESPR) over the last 1 years, with Sep 2025 value amounting to 0.42.

  • Esperion Therapeutics' Debt Ratio was N/A to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42, marking a year-over-year change of. This contributed to the annual value of 0.41 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Esperion Therapeutics' Debt Ratio is 0.42, which was down 1.27% from 0.42 recorded in Q2 2025.
  • Esperion Therapeutics' 5-year Debt Ratio high stood at 0.44 for Q1 2025, and its period low was 0.41 during Q4 2024.
  • Its 2-year average for Debt Ratio is 0.42, with a median of 0.42 in 2025.